Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing medications, has a good shot at reaching market.

TC BioPharm has signed a non-binding LoI to acquire a pharma company focused on commercialising intraocular pressure ...

Kennedy can provide doctors and healthcare professionals with the information they need to truly determine if a drug is safe, ...

SEOUL, South Korea, March 6, 2025 /PRNewswire/ -- NEXTBIOMEDICAL CO., LTD, a leading developer of cutting-edge Devices, announced that its groundbreaking product 'Nexsphere-F™,' a resorbable ...

The U.S. embassy in Lima, Peru, is warning Americans against a traditional psychedelic known as ayahuasca, cautioning that ...

Over 31 million Americans borrowed a collective $74 billion to pay for healthcare last year, a West Health-Gallup survey ...

Vitestro, a pioneer in medical robotics, proudly reveals the name of its autonomous blood drawing device: Aletta, the first autonomous ...